2.2. Participants
renal dysfunction, diabetes
ADVERSE REACTIONS, COMPLICATIONS, DIABETES
The main selection criteria for patients were as follows: age between 20 and 80 years, HbA1c ≥ 6.5%, hospitalized type two diabetes patients, and documented consent to participate in the study. The main exclusion criteria were as follows: patients taking alpha-glucosidase inhibitors, patients with a history of serious adverse reactions to D-allulose in the past, and patients with serious complications or serum creatinine ≥1.5 mg/dL (severe renal dysfunction). Pregnant, parturient, lactating, or possibly pregnant women; patients participating in other studies; or those deemed by their physician to be inappropriate for study participation were also excluded.